These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 355064)

  • 61. Serum squalene levels in hepatobiliary diseases.
    Yamanishi Y; Ikawa S; Hirayama C
    Clin Chim Acta; 1978 Aug; 88(1):105-10. PubMed ID: 679482
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenetic mechanisms.
    Goldberg DM; Brown D
    Clin Biochem; 1987 Apr; 20(2):127-48. PubMed ID: 3301064
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical value of serum concentration of total bile acids in chronic hepatopathies].
    Pazzi P; Arlotti A; Stabellini G; Trevisani L; Sartori S; Faggioli M
    Minerva Med; 1985 Jan; 76(3-4):105-12. PubMed ID: 3974919
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The diagnostic value of bile acid and cholesterol determination in bile].
    Kipshidze NN; Lezhava DI
    Ter Arkh; 1971 Apr; 43(4):61-6. PubMed ID: 5123442
    [No Abstract]   [Full Text] [Related]  

  • 65. Within-day fluctuations in serum bile-acid concentrations among normal control subjects and patients with hepatic disease.
    Engelking LR; Dasher CA; Hirschowitz BI
    Am J Clin Pathol; 1980 Feb; 73(2):196-201. PubMed ID: 7188830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic value of serum bile acid determination in chronic hepatitis and liver cirrhosis.
    Grigorescu M; Tăpălagă D; Dumitraşcu D; Suciu A
    Med Interne; 1980; 18(4):401-6. PubMed ID: 7455585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography.
    Okuda H; Obata H; Nakanishi T; Hisamitsu T; Matsubara K; Watanabe H
    Hepatogastroenterology; 1984 Aug; 31(4):168-71. PubMed ID: 6479837
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Laboratory Evaluation of the Liver.
    Lawrence YA; Steiner JM
    Vet Clin North Am Small Anim Pract; 2017 May; 47(3):539-553. PubMed ID: 28063744
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Initial and expanded diagnosis of liver diseases in childhood].
    Burdelski M; Hoyer PF; Oemar BS
    Monatsschr Kinderheilkd; 1987 Jul; 135(7):450-5. PubMed ID: 3627134
    [No Abstract]   [Full Text] [Related]  

  • 70. [Fasting and postprandial serum bile acids in chronic liver diseases].
    Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G
    Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170
    [No Abstract]   [Full Text] [Related]  

  • 71. [Activity of xanthine oxidase in the blood serum in patients with surgical diseases of the liver and bile ducts and other diseases].
    Diachina EG
    Lab Delo; 1973; 11():647-9. PubMed ID: 4132561
    [No Abstract]   [Full Text] [Related]  

  • 72. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Evaluation of fasting and postprandial serum bile acid concentrations in hepatobiliary diseases].
    Cheng TC; Chen CF; Chou PT; Sheen TY
    Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):413-21. PubMed ID: 3598551
    [No Abstract]   [Full Text] [Related]  

  • 74. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts.
    Roy CC; Weber AM; Morin CL; Lepage G; Brisson G; Yousef I; Lasalle R
    J Pediatr Gastroenterol Nutr; 1982; 1(4):469-78. PubMed ID: 7186061
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bile acid concentrations in the diagnosis of hepatobiliary disease in the dog.
    Center SA; Baldwin BH; Erb HN; Tennant BC
    J Am Vet Med Assoc; 1985 Nov; 187(9):935-40. PubMed ID: 4055519
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spectacular elevations of serum alkaline phosphatase: clinical and pathological correlation.
    Patton RB
    Henry Ford Hosp Med J; 1970; 18(3):211-4. PubMed ID: 5456488
    [No Abstract]   [Full Text] [Related]  

  • 77. Blood chemistry for the diagnosis of hepatobiliary disease in birds. A review.
    Lumeij JT; Westerhof I
    Vet Q; 1987 Jul; 9(3):255-61. PubMed ID: 3314104
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The clinical value of analysis of serum bile acid concentration].
    Linnet K
    Ugeskr Laeger; 1981 Aug; 143(36):2294-7. PubMed ID: 7029843
    [No Abstract]   [Full Text] [Related]  

  • 79. Profiles of serum isoenzymes of alkaline phosphatase in hepatobiliary disorders using cellulose acetate electrophoresis and organ-specific inhibitors.
    Rhone DP; Mizuno FM; Gidaspow H
    Ann Clin Lab Sci; 1973; 3(5):353-61. PubMed ID: 4756765
    [No Abstract]   [Full Text] [Related]  

  • 80. Serum bile acids and rountine liver function tests in patients with chronic liver disease and cholestasis.
    Collins DM; Tongeren AV; Cook HB; Campbell CB
    N Z Med J; 1979 Jun; 89(637):432-4. PubMed ID: 289016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.